AIM ImmunoTech Inc (NYSE American:AIM)
| 0.5475 Delayed Data As of 3:42pm ET |  -0.0136 / -2.42%Today’s Change | 0.29 Today|||52-Week Range 0.84 | +75.54% Year-to-Date |
Latest AIM News | Press Releases
No recent news for AIM ImmunoTech Inc.
Today’s Trading
| Previous close | 0.56 |
| Today’s open | 0.56 |
| Day’s range | 0.55 - 0.56 |
| Volume | 79,052 |
| Average volume (3 months) | 120,375 |
| Market cap | $23.3M |
Data as of 3:42pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | -0.17% |
| Earnings growth (this year) | -5.00% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +4.44% |
| P/E ratio | NM |
| Price/Sales | 106.28 |
| Price/Book | 0.61 |
Competitors
Data as of 3:49pm ET, 12/08/2023
Financials
| Next reporting date | April 1, 2024 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $141.0K |
| Annual profit (last year) | -$19.4M |
| Net profit margin | -13,790.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Ocala, Florida |
Forecasts
